U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07163988) titled 'CCS-AMI Staging Diagnosis by High-sensitivity Cardiac Troponin-I' on Sept. 01.
Brief Summary: MIRON-CCS is a multicenter retrospective diagnostic study designed to evaluate the role of high-sensitivity cardiac troponin I (hs-cTnI) in the diagnosis and clinical stage classification of acute myocardial infarction (AMI) as defined by the Canadian Cardiovascular Society (CCS) AMI staging system.
The study retrospectively analyzes biomarker data from patients diagnosed with AMI across multiple institutions, focusing on whether hs-cTnI levels-measured at specific time points-can reliably identify and stratify patients into CCS-defined A...